Literature DB >> 19666475

NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.

Laura A Solt1, Lisa A Madge, Michael J May.   

Abstract

Proinflammatory NF-kappaB activation requires the IkappaB (inhibitor of NF-kappaB) kinase (IKK) complex that contains two catalytic subunits named IKKalpha and IKKbeta and a regulatory subunit named NF-kappaB essential modulator (NEMO). NEMO and IKKbeta are essential for tumor necrosis factor (TNF)-induced NF-kappaB activation, and we recently demonstrated that NEMO and IKKalpha are sufficient for interleukin (IL)-1-induced signaling. IKKalpha and IKKbeta both contain a functional NEMO-binding domain (NBD); however, the role of NEMO association with each kinase in NF-kappaB signaling and IKK complex formation remains unclear. To address this question, we stably reconstituted IKKalpha(-/-) and IKKbeta(-/-) murine embryonic fibroblasts (MEFs) with wild-type (WT) or NBD-deficient (DeltaNBD) versions of IKKalpha and IKKbeta, respectively. TNF-induced classical NF-kappaB activation in IKKbeta(-/-) MEFs was rescued by IKKbeta(WT) but not IKKbeta(DeltaNBD), whereas neither IKKbeta(WT) nor IKKbeta(DeltaNBD) affected IL-1-induced NF-kappaB signaling. As previously described, classical NF-kappaB transcriptional activity was absent in IKKalpha(-/-) cells. Reconstitution with either IKKalpha(WT) or IKKalpha(DeltaNBD) rescued both IL-1 and TNF-induced transcription, demonstrating that NEMO association is not required for IKKalpha-dependent regulation of NF-kappaB-dependent transcription. Stably expressed IKKalpha(WT) or IKKbeta(WT) associated with endogenous IKKs and NEMO in IKKalpha(-/-) or IKKbeta(-/-) MEFs, respectively, resulting in formation of the heterotrimeric IKKalpha-IKKbeta-NEMO complex. In contrast, although the IKKalpha(DeltaNBD) and IKKbeta(DeltaNBD) mutants associated with endogenous IKKs containing an NBD, these dimeric endogenous IKK-IKK(DeltaNBD) complexes did not associate with NEMO. These findings therefore demonstrate that formation of the heterotrimeric IKKalpha-IKKbeta-NEMO holocomplex absolutely requires two intact NEMO-binding domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666475      PMCID: PMC2785688          DOI: 10.1074/jbc.M109.047563

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

2.  Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.

Authors:  Nywana Sizemore; Natalia Lerner; Nicole Dombrowski; Hiroaki Sakurai; George R Stark
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

3.  IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex.

Authors:  F Mercurio; B W Murray; A Shevchenko; B L Bennett; D B Young; J W Li; G Pascual; A Motiwala; H Zhu; M Mann; A M Manning
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  Primary human CD4+ T cells contain heterogeneous I kappa B kinase complexes: role in activation of the IL-2 promoter.

Authors:  A Khoshnan; S J Kempiak; B L Bennett; D Bae; W Xu; A M Manning; C H June; A E Nel
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

5.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

Authors:  C Makris; V L Godfrey; G Krähn-Senftleben; T Takahashi; J L Roberts; T Schwarz; L Feng; R S Johnson; M Karin
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

6.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.

Authors:  M J May; F D'Acquisto; L A Madge; J Glöckner; J S Pober; S Ghosh
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation.

Authors:  S Q Zhang; A Kovalenko; G Cantarella; D Wallach
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

8.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

Authors:  D Rudolph; W C Yeh; A Wakeham; B Rudolph; D Nallainathan; J Potter; A J Elia; T W Mak
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

9.  IKKalpha controls formation of the epidermis independently of NF-kappaB.

Authors:  Y Hu; V Baud; T Oga; K I Kim; K Yoshida; M Karin
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

10.  Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.

Authors:  Lloyd T Lam; R Eric Davis; Vu N Ngo; Georg Lenz; George Wright; Weihong Xu; Hong Zhao; Xin Yu; Lenny Dang; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

View more
  18 in total

1.  The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-κB activation by interacting with the IκB kinase complex.

Authors:  Crystal M H Randall; Janet A Jokela; Joanna L Shisler
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

2.  NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.

Authors:  Anita Gaurnier-Hausser; Reema Patel; Albert S Baldwin; Michael J May; Nicola J Mason
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

3.  Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB.

Authors:  Claus Johansen; Jette L Riis; Anne Gedebjerg; Knud Kragballe; Lars Iversen
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

4.  Polyubiquitin Drives the Molecular Interactions of the NF-κB Essential Modulator (NEMO) by Allosteric Regulation.

Authors:  Dragana A M Catici; James E Horne; Grace E Cooper; Christopher R Pudney
Journal:  J Biol Chem       Date:  2015-04-12       Impact factor: 5.157

5.  Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate.

Authors:  Leyuan Xu; Qianming Bai; Daniel Rodriguez-Agudo; Phillip B Hylemon; Douglas M Heuman; William M Pandak; Shunlin Ren
Journal:  Lipids       Date:  2010-08-11       Impact factor: 1.880

6.  Cutting edge: association with I kappa B kinase beta regulates the subcellular localization of Homer3.

Authors:  Gayatri Yatherajam; Pinaki P Banerjee; Kelly A McCorkell; Laura A Solt; Eric P Hanson; Lisa A Madge; Shin Kang; Paul F Worley; Jordan S Orange; Michael J May
Journal:  J Immunol       Date:  2010-08-06       Impact factor: 5.422

7.  Targeting of NF-κB to Dendritic Spines Is Required for Synaptic Signaling and Spine Development.

Authors:  Erica C Dresselhaus; Matthew C H Boersma; Mollie K Meffert
Journal:  J Neurosci       Date:  2018-03-19       Impact factor: 6.167

8.  Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.

Authors:  Eric T Baima; Julia A Guzova; Sumathy Mathialagan; Eva E Nagiec; Medora M Hardy; Lily R Song; Sheri L Bonar; Robin A Weinberg; Shaun R Selness; Scott S Woodard; Jill Chrencik; William F Hood; John F Schindler; Nandini Kishore; Gabriel Mbalaviele
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

9.  Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling.

Authors:  Xiu Q Zhang; Ruhang Tang; Ling Li; Amanda Szucsik; Hadi Javan; Noriko Saegusa; Ken W Spitzer; Craig H Selzman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

10.  Noncanonical NF-κB signaling is limited by classical NF-κB activity.

Authors:  Carolyn M Gray; Caroline Remouchamps; Kelly A McCorkell; Laura A Solt; Emmanuel Dejardin; Jordan S Orange; Michael J May
Journal:  Sci Signal       Date:  2014-02-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.